Single-fraction SBRT with Radixact for lung malignancies: early outcomes of a single-center experience
Francesco Cuccia, Italy | ESTRO | 2026
Early post-SBRT CT patterns and dosimetric factors predict recurrence in solitary lung nodules
María Pagola | ESTRO | 2026
STereotActic Radiotherapy in LOcally advanced non-small cell lung cancer unfit for concurRent chemoraDiation:preliminary results of the STARLORD study
Francesco Cuccia | ESTRO | 2026
Stereotactic radiotherapy for non-spine bone metastases: a mono-institutional experience
Francesco Cuccia | ESTRO | 2026
STEREOTACTIC BODY RADIOTHERAPY FOR PERITONEAL OR ABDOMINAL WALL OLIGOMETASTASES: PRELIMINARY RESULTS FROM A MONO-INSTITUTIONAL ANALYSIS
Francesco Cuccia | ESTRO | 2026
One-year cumulative toxicity in 25 prostate cancer patients treated with single fraction (24 Gy) urethra-sparing radiosurgery (PRO-FAST NCT05936736 )
Andrei Fodor, Italy | ESTRO | 2026
Cyberknife UH-SBRT for localized Prostate cancer and DIL: preliminary report of acute and late side effects of the prospective PRO-SPEED trial
Karl Amin, Italy | ESTRO | 2026
EARLY FINDINGS FROM THE STARR (NCT05455736) TRIAL:STEREOTACTIC SALVAGE RADIOTHERAPY FOR MACROSCOPIC RECURRENCE IN THE PROSTATE BED POST-PROSTATECTOMY
Niccolo’ Bertini | ESTRO | 2026
Impact of alternating-day fractionation on treatment outcome and toxicity in CyberKnife prostate SBRT
Michaela Jindráková, Czech Republic | ESTRO | 2026
Stereotactic body radiation therapy for intermediate-risk prostate cancer: efficacy and toxicity
María Dolores Espinosa Cuesta | ESTRO | 2026
DVH-based analysis of genitourinary side effects in robotic SBRT prostate treatments
David Sevillano, Spain | ESTRO | 2026
Planning, patient QA and image-guidance aspects of single-fraction, one-Day robotic SBRT for localized prostate cancer.
SARA BROGGI, Italy | ESTRO | 2026
Cyberknife Radiosurgery of Prostate Cancer – Results for 200 Patients
Sebastian Exner, Germany | ESTRO | 2026
Pathological downstaging and molecular biomarkers after pre-operative radiosurgery in early-stage breast cancer: The CRYSTAL study
Marco Lucarelli | ESTRO | 2026
Dosimetric comparison of left-sided accelerated partial breast irradiation (APBI) performed with conventional linear accelerator and CyberKnife
Enikő Koszta, Hungary | ESTRO | 2026
Stereotactic Accelerated Partial Breast Irradiation Using CyberKnife – 5-Year Results of a single-institution Phase II trial.
Norbert Mészáros, Hungary | ESTRO | 2026
Preoperative radiotherapy in a single fraction for early stage breast cancer: the CRYSTAL phase I/II study update (AIRC IG-23118)
Maria Alessia Zerella | ESTRO | 2026
Dosimetric analysis for single fraction radiation therapy in breast cancer: CRYSTAL trial
Marco Lucarell | ESTRO | 2026
Long-term Outcomes of Ablative Stereotactic Body Radiation Therapy for Inoperable, Non-metastatic Pancreatic Cancer
Cao BY, Zhang LT, Wu CC, Wang J | Radiother Oncol. | 2025
Investigating the Efficacy and Safety of the CyberKnife System for Treating Primary Pancreatic Cancer with Metastases to the Gastrointestinal Tract
Zhang Z, Tian B, Xu H, Huang H, Liang X, Bo C, Bian Y, Wei M, Zhao Z | Cancer Manag Res | 2025
